Revolade 50 mg film-coated tablets
Sponsors
Fakultni Nemocnice Hradec Kralove, Associazione Qol-One
Conditions
Immune thrombocytopeniaMyelodysplastic syndromes
Phase 2
Complex immunomodulatory therapy for patients with immune thrombocytopenia (T-MEM)
RecruitingCTIS2023-505788-35-00
Start: 2025-06-11Target: 50Updated: 2025-05-29
Eltrombopag for the treatment of thrombocytopenia due to low - and intermediate risk myelodysplastic syndromes.
Not yet recruitingCTIS2024-520133-72-00
Target: 160Updated: 2025-06-24